These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 25819051)

  • 21. Performance of the fourth-generation Bio-Rad GS HIV Combo Ag/Ab enzyme immunoassay for diagnosis of HIV infection in Southern Africa.
    Piwowar-Manning E; Fogel JM; Richardson P; Wolf S; Clarke W; Marzinke MA; Fiamma A; Donnell D; Kulich M; Mbwambo JK; Richter L; Gray G; Sweat M; Coates TJ; Eshleman SH
    J Clin Virol; 2015 Jan; 62():75-9. PubMed ID: 25542477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative multi-assay evaluation of Determine™ HIV-1/2 Ag/Ab Combo rapid diagnostic tests in acute and chronic HIV infection.
    Wratil PR; Rabenau HF; Eberle J; Stern M; Münchhoff M; Friedrichs I; Stürmer M; Berger A; Kuttner-May S; Münstermann D; Lucht A; Meixenberger K; Bannert N; Keppler OT
    Med Microbiol Immunol; 2020 Apr; 209(2):139-150. PubMed ID: 32036450
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the siemens HIV antigen-antibody immunoassay.
    Vallefuoco L; Aden Abdi F; Sorrentino R; Spalletti-Cernia D; Mazzarella C; Barbato S; Perna E; Buffolano W; Di Nicuolo G; Portella G
    Intervirology; 2014; 57(2):106-11. PubMed ID: 24557036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of an alternative HIV diagnostic algorithm using the ARCHITECT HIV Ag/Ab Combo assay and potential utility of sample-to-cutoff ratio to discriminate primary from established infection.
    Ramos EM; Harb S; Dragavon J; Swenson P; Stekler JD; Coombs RW
    J Clin Virol; 2013 Dec; 58 Suppl 1(0 1):e38-43. PubMed ID: 24029686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Performance evaluation of the Bio-Rad Laboratories GS HIV Combo Ag/Ab EIA, a 4th generation HIV assay for the simultaneous detection of HIV p24 antigen and antibodies to HIV-1 (groups M and O) and HIV-2 in human serum or plasma.
    Bentsen C; McLaughlin L; Mitchell E; Ferrera C; Liska S; Myers R; Peel S; Swenson P; Gadelle S; Shriver MK
    J Clin Virol; 2011 Dec; 52 Suppl 1():S57-61. PubMed ID: 21995929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of serological and molecular tests within acute HIV infection.
    Fransen K; de Baetselier I; Rammutla E; Ahmed K; Owino F; Agingu W; Venter G; Deese J; Van Damme L; Crucitti T;
    J Clin Virol; 2017 Aug; 93():81-84. PubMed ID: 28351688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance evaluation of the ADVIA Centaur(®) HIV Ag/Ab Combo assay.
    Pumarola T; Freeman J; Saxton E; Dillon P; Bal T; van Helden J
    J Virol Methods; 2010 Dec; 170(1-2):16-20. PubMed ID: 20723562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the performance of the Abbott ARCHITECT HIV Ag/Ab Combo Assay.
    Chavez P; Wesolowski L; Patel P; Delaney K; Owen SM
    J Clin Virol; 2011 Dec; 52 Suppl 1():S51-5. PubMed ID: 21983253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance evaluation of a new fourth-generation HIV Ag/Ab combination electrochemiluminescence immunoassay - evaluation of a new HIV assay.
    Wang T; Li D; Yan K; Yuan Y; Yang T; Du X; Yan X; Tao C; Wang L
    Int J STD AIDS; 2014 Mar; 25(4):267-72. PubMed ID: 23970655
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of dried blood spot protocols with the Bio-Rad GS HIV Combo Ag/Ab EIA and Geenius™ HIV 1/2 Supplemental Assay.
    Luo W; Davis G; Li L; Shriver MK; Mei J; Styer LM; Parker MM; Smith A; Paz-Bailey G; Ethridge S; Wesolowski L; Owen SM; Masciotra S
    J Clin Virol; 2017 Jun; 91():84-89. PubMed ID: 28366544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specificity of two HIV screening tests detecting simultaneously HIV-1 p24 antigen and antibodies to HIV-1 and -2.
    Blaich A; Buser A; Stöckle M; Gehringer C; Hirsch HH; Battegay M; Klimkait T; Frei R
    J Virol Methods; 2017 Nov; 249():143-146. PubMed ID: 28893550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure of fourth-generation enzyme immunoassay in HIV screening and plasma HIV-1 RNA detection in recent high-risk behavior.
    Maylin S; Fouéré S; Simon F; Delaugerre C
    Intervirology; 2014; 57(1):49-51. PubMed ID: 24157685
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Role of line immunoassay in the diagnosis of early HIV infection: a diagnostic case].
    Soylar M; Altuğlu I; Sertöz R; Gökengin D
    Mikrobiyol Bul; 2013 Jul; 47(3):567-9. PubMed ID: 23971936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Field evaluation of the Abbott ARCHITECT HIV Ag/Ab Combo immunoassay.
    Kfutwah A; Lemée V; Ngono HV; De Oliveira F; Njouom R; Plantier JC
    J Clin Virol; 2013 Dec; 58 Suppl 1():e70-5. PubMed ID: 24342480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosing acute HIV infection at point of care: a retrospective analysis of the sensitivity and specificity of a fourth-generation point-of-care test for detection of HIV core protein p24.
    Fitzgerald N; Cross M; O'Shea S; Fox J
    Sex Transm Infect; 2017 Mar; 93(2):100-101. PubMed ID: 27272704
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.
    Parker J; Carrasco AF; Chen J
    J Clin Virol; 2019 Jul; 116():1-3. PubMed ID: 30981082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of acute HIV infection: a field evaluation of the determine® HIV-1/2 Ag/Ab combo test.
    Rosenberg NE; Kamanga G; Phiri S; Nsona D; Pettifor A; Rutstein SE; Kamwendo D; Hoffman IF; Keating M; Brown LB; Ndalama B; Fiscus SA; Congdon S; Cohen MS; Miller WC
    J Infect Dis; 2012 Feb; 205(4):528-34. PubMed ID: 22207651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of HIV Screening Tests for Use in Preexposure Prophylaxis Programs.
    Delaugerre C; Antoni G; Mahjoub N; Pialoux G; Cua E; Pasquet A; Hall N; Tremblay C; Cotte L; Capitant C; Chaix ML; Meyer L; Molina JM;
    J Infect Dis; 2017 Aug; 216(3):382-386. PubMed ID: 28666370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A signal-to-cutoff ratio in the Abbott architect HIV Ag/Ab Combo assay that predicts subsequent confirmation of HIV-1 infection in a low-prevalence setting.
    Jensen TO; Robertson P; Whybin R; Chambers I; Lahra M; Rawlinson W; Post JJ
    J Clin Microbiol; 2015 May; 53(5):1709-11. PubMed ID: 25673794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the ability of a fourth-generation immunoassay for human immunodeficiency virus (HIV) antibody and p24 antigen to detect both acute and recent HIV infections in a high-risk setting.
    Pandori MW; Hackett J; Louie B; Vallari A; Dowling T; Liska S; Klausner JD
    J Clin Microbiol; 2009 Aug; 47(8):2639-42. PubMed ID: 19535523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.